Received May 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | 1 | — | — |
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | 1 | — | — |
No symptomatic adverse events were reported; patient inadvertently received RECOMBIVAX HB and VAXELIS on the same day; This spontaneous report was received from a Licensed Nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 20-May-2025, the patient inadvertently vaccinated with Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB),, dose number 1, (lot # and expiration date were not reported) and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed, Inactivated Poliovirus(VAXELIS), dose number 1, (lot # and expiration date were not reported) (accidental overdose). No adverse event was reported.; Reporter's Comments: